Patrizia Nigro
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis.
Journal: International journal of biological sciences
Published: December 18, 2020
Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients.
Journal: Cells
Published: November 04, 2019
Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.
Journal: International journal of molecular sciences
Published: April 15, 2019
Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients.
Journal: Theranostics
Published: October 16, 2018
Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its Solution.
Journal: Progress in cardiovascular diseases
Published: July 19, 2018
Integrin ανβ5 in vitro inhibition limits pro-fibrotic response in cardiac fibroblasts of spontaneously hypertensive rats.
Journal: Journal of translational medicine
Published: June 15, 2018
Fibrosis Rescue Improves Cardiac Function in Dystrophin-Deficient Mice and Duchenne Patient-Specific Cardiomyocytes by Immunoproteasome Modulation.
Journal: The American journal of pathology
Published: April 23, 2018
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Published: August 01, 2017
Cell Therapy for Refractory Angina: A Reappraisal.
Journal: Stem cells international
Published: July 28, 2017
Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).
Journal: Stem cell research
Published: April 04, 2017
Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
Journal: Stem cell research
Published: April 04, 2017
Cell therapy for heart disease after 15 years: Unmet expectations.
Journal: Pharmacological research
Published: September 30, 2016
Last Updated: 09/26/2026